Inventor profile of:

Robert Joseph Stagg

City:

Moraga, California

Country:

United States

Published Applications:

13

Last publication date:

2019-01-24

Top Assignees for applications by Robert Joseph Stagg

The entities that hold a legal rights for patent applications filed by inventor Stagg Robert Joseph:

Recent patent applications by Stagg Robert Joseph

Robert Joseph Stagg from Moraga, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-01-24
US20190023776A1
Chemistry; metallurgy

Methods and compositions for treatment of cancer

#2 | 2018-12-06
US20180346556A1
Chemistry; metallurgy

Therapeutic combination and methods of treatment with a DLL4 antagonist and an anti-hypertensive agent

#3 | 2017-10-19
US20170299598A1
Physics

Methods and Monitoring of Treatment With A DLL4 Antagonist

#4 | 2017-06-15
US20170166632A1
Chemistry; metallurgy

Therapeutic combination and methods of treatment with a DLL4 antagonist and an anti-hypertensive agent

#5 | 2016-11-17
US20160334423A1
Physics

METHODS AND MONITORING OF TREATMENT WITH A DLL4 ANTAGONIST

#6 | 2016-11-10
US20160324961A1
Human necessities

Methods for Treating Cancer with DLL4 Antagonists

#7 | 2016-08-18
US20160235844A1
Human necessities

METHODS OF TREATING NEUROENDOCRINE TUMORS USING FRIZZLED-BINDING AGENTS

#8 | 2015-04-30
US20150118232A1
Human necessities

Therapeutic combination and methods of treatment with a DLL4 antagonist and an anti-hypertensive agent

#9 | 2014-08-14
US20140227252A1
Physics

Methods and Monitoring of Treatment with a DLL4 Antagonist

#10 | 2014-08-07
US20140220001A1
Physics

Methods and monitoring of treatment with a DLL4 antagonist

#11 | 2014-05-15
US20140134159A1
Chemistry; metallurgy

Methods of treating neuroendocrine tumors using frizzled-binding agents

#12 | 2013-12-05
US20130323265A1
Human necessities

METHODS FOR TREATING CANCER WITH DLL4 ANTAGONISTS

#13 | 2012-10-18
US20120263721A1
Chemistry; metallurgy

Methods of treatment with DLL4 antagonists and an anti-hypertensive agent

InventorID:

557321 ⎘